Relay Therapeutics’ combination therapy slows breast cancer progression in early trial
Relay Therapeutics said on Monday that interim data from an early trial of its combination breast cancer drug showed it significantly increased patients’ life expectancy without worsening the course of the disease, sending shares up about 37% in early trading.
ПОПУЛЯРНЫЕ ПОСТЫ
Portugal declares risk as wildfires hit the north of the country
Сентябрь 17, 2024
UK to appoint nature envoy
Сентябрь 17, 2024
Death tolls rises as Central Europe floods
Сентябрь 17, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ